TrialThe patient2022

Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.

Ana-Maria Orbai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.